引用本文: | 乔贵宾, 程华. KRAS基因突变与肺腺癌对Gefitinib和Erlotinib原发耐药的关系[J]. 循证医学, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007 |
Citation: | QIAO Gui-bin, CHENG Hua. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 216-218. DOI: 10.3969/j.issn.1671-5144.2008.04.007 |